Cooperative Agreement U44NS104138

The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $3,565,780 Project Grant under the Drug Use and Addiction Research Programs (CFDA 93.279) to The General Hospital Corporation, doing business as Massachusetts General Hospital (MGH), to develop a groundbreaking high-frequency trans-spinal magnetic stimulation (HF-TSMS) system for the non-invasive treatment of neuropathic pain. The funded project aims to create an HF-TSMS tool that can target neural pathways involved in...

This $652,497 Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, supports a study on the neurological substrates of proximal upper extremity motor control and recovery after stroke. The primary awardee, The General Hospital Corporation (doing business as Massachusetts General Hospital), will conduct three specific aims: (1)...

This $750,000 Project Grant from the National Science Foundation's Technology, Innovation, and Partnerships program will fund the development of appropriate rehabilitation technology for stroke survivors through passive tactile stimulation. The Leland Stanford Junior University will lead an interdisciplinary team including universities, hospitals, and community organizations to finalize the team composition, generate use cases, and develop a comprehensive research plan including initial...

This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS) under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) provides $299,982 to support the development of Unandup, LLC's novel magnetic infusion platform technology. The goal is to evaluate the safety and efficacy of this adjunctive thrombolysis system in an in vivo rat model of acute ischemic stroke. The technology aims to accelerate the delivery of...

This federal Project Grant award, provided by the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865), aims to investigate neuromodulatory strategies to improve paretic leg motor control during walking in individuals with stroke. The $148,568 grant, awarded on May 28, 2025, with a completion date of November 30, 2026, has two primary objectives: (1) to determine the effects of transcutaneous...

Teliatry Inc. received a $768,138 project grant award from the National Institutes of Health's National Institute of Biomedical Imaging and Bioengineering to develop a minimally invasive, single incision, rechargeable spinal cord stimulation system for chronic pain management. The grant was awarded under the Discovery and Applied Research for Technological Innovations to Improve Human Health program. Through this award, Teliatry will engineer the world's smallest (0.75cc), most cost-effective...

This federal Cooperative Agreement award, totaling $1,594,319.00, was provided by the National Institute of Neurological Disorders and Stroke (NINDS) under the Drug Use and Addiction Research Programs (CFDA 93.279) to the University of Texas Health Science Center at Houston (UTHealth). The award aims to develop and test an innovative, non-invasive device called Breathing-Controlled Electrical Stimulation (BREESTIM) for the management of neuropathic pain after spinal cord injury. The project...

This Project Grant award from the National Institute of Neurological Disorders and Stroke (NINDS), under the Extramural Research Programs in the Neurosciences and Neurological Disorders (CFDA 93.853) federal grant program, will provide $633,683 to the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University over a 5-year period from August 1, 2024 to July 31, 2029. The project aims to study how deep brain stimulation (DBS) can promote brain reorganization and motor recovery...

The National Institute of Neurological Disorders and Stroke (NINDS) awarded a $423,500 Project Grant (CFDA 93.853 - Extramural Research Programs in the Neurosciences and Neurological Disorders) to the Augusta University Research Institute, Inc. The objective is to develop and evaluate engineered exosomes carrying neuron-targeting peptides and a therapeutic protein (neuroglobin) for treating ischemic stroke. The research will: 1) characterize the engineered exosomes and assess their...

This Project Grant award from the National Institute of Child Health and Human Development (NICHD), under the Child Health and Human Development Extramural Research program (CFDA 93.865), provides $343,510 to Theranova LLC, a veteran-owned medical device company based in San Francisco, to conduct a pilot clinical study evaluating the SOLESTIM neuromodulation system as a treatment for dysmenorrhea (menstrual cramps). The SOLESTIM system is a portable, non-invasive device that uses plantar...